Treatment of methemoglobinemia is done with –
**Core Concept**
Methemoglobinemia is a disorder characterized by an abnormal increase in methemoglobin, a form of hemoglobin that cannot bind oxygen. The treatment of methemoglobinemia involves reducing methemoglobin to normal hemoglobin, which can be achieved through various pharmacological interventions.
**Why the Correct Answer is Right**
The primary treatment for methemoglobinemia involves the administration of methylene blue, a drug that acts as a reducing agent. Methylene blue is reduced to leucomethylene blue, which then donates electrons to methemoglobin, converting it back to normal hemoglobin. This process is mediated by the enzyme NADPH cytochrome P450 reductase, which is present in the cytosol of red blood cells. Methylene blue is the treatment of choice for methemoglobinemia because it is effective, relatively safe, and can be administered intravenously or orally.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because methylene blue is the specific treatment for methemoglobinemia, not a general term for reducing agents.
**Option B:** This option is incorrect because vitamin B12 is involved in the metabolism of fatty acids and amino acids, but it is not a treatment for methemoglobinemia.
**Option C:** This option is incorrect because folic acid is a B vitamin that plays a crucial role in DNA synthesis and repair, but it is not used to treat methemoglobinemia.
**Clinical Pearl / High-Yield Fact**
Methemoglobinemia can be caused by a variety of factors, including certain medications (such as local anesthetics and antimalarial drugs), toxins (such as nitrites and nitrates), and genetic disorders. It is essential to recognize the symptoms of methemoglobinemia, which include cyanosis, shortness of breath, and fatigue, and to initiate treatment promptly to prevent complications.
**Correct Answer: C. Methylene blue**